Three polymorphisms in interleukin-1β gene and risk for breast cancer: A meta-analysis

Breast Cancer Research and Treatment

Volumn 124, Issue 3, 2010, Pages 821-825

  Liu, Xiaoan ^a   Wang, Zhanwei ^a   Yu, Jinhua ^a   Lei, Gang ^a   Wang, Shui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Interleukin 1 ; Meta analysis; Polymorphism

Indexed keywords

INTERLEUKIN 1BETA;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1BETA; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 78649288528     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0910-3     Document Type: Article

References (20)

1. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 1:CAS:528:DC%2BD38XpsFygtb4%3D 10.1038/nature01322 12490959 (Pubitemid 36019639)
2. V Speirs MJ Kerin CJ Newton DS Walton AR Green SB Desai SL Atkin 1999 Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells Int J Oncol 15 1251 1254 1:CAS:528:DC%2BD3cXhsVelsQ%3D%3D 10568836
3. S Honma K Shimodaira Y Shimizu N Tsuchiya H Saito T Yanaihara T Okai 2002 The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells Endocr J 49 371 377 1:CAS:528:DC%2BD38XntVeru7w%3D 10.1507/endocrj.49.371 12201223
4. Y Momiyama R Hirano H Taniguchi H Nakamura F Ohsuzu 2001 Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection J Am Coll Cardiol 38 712 717 1:CAS:528:DC%2BD3MXntlaitL0%3D 10.1016/S0735-1097(01)01438-3 11527622 (Pubitemid 32835741)
5. C Eklund F Jahan T Pessi T Lehtimaki M Hurme 2003 Interleukin 1B gene polymorphism is associated with baseline C-reactive protein levels in healthy individuals Eur Cytokine Netw 14 168 171 1:CAS:528:DC%2BD3sXovVKit7o%3D 14656692
6. F Pociot J Molvig L Wogensen H Worsaae J Nerup 1992 A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro Eur J Clin Invest 22 396 402 1:CAS:528:DyaK3sXitVKltA%3D%3D 10.1111/j.1365-2362.1992.tb01480.x 1353022
7. LS Ito H Iwata N Hamajima T Saito K Matsuo M Mizutani T Iwase S Miura K Okuma M Inoue K Hirose K Tajima 2002 Significant reduction in breast cancer risk for Japanese women with interleukin 1B-31 CT/TT relative to CC genotype Jpn J Clin Oncol 32 398 402 10.1093/jjco/hyf081 12451035 (Pubitemid 43102775)
8. E Akisik N Dalay 2007 Functional polymorphism of thymidylate synthase, but not of the COMT and IL-1B genes, is associated with breast cancer J Clin Lab Anal 21 97 102 1:CAS:528:DC%2BD2sXkvVWqsbk%3D 10.1002/jcla.20139 17385677 (Pubitemid 46536881)
9. SP Balasubramanian IA Azmy SE Higham AG Wilson SS Cross A Cox NJ Brown MW Reed 2006 Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review BMC Cancer 6 188 1:STN:280: DC%2BD28rgs1aqug%3D%3D 10.1186/1471-2407-6-188 16842617 (Pubitemid 44295087)
10. LA Hefler C Grimm T Lantzsch D Lampe S Leodolter H Koelbl G Heinze A Reinthaller D Tong-Cacsire C Tempfer R Zeillinger 2005 Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in Caucasian women Clin Cancer Res 11 5718 5721 1:CAS:528:DC%2BD2MXos1Cjsb4%3D 10.1158/1078-0432.CCR-05-0001 16115908 (Pubitemid 41170295)
11. KM Lee SK Park N Hamajima K Tajima JY Choi DY Noh SH Ahn KY Yoo A Hirvonen D Kang 2006 Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women Breast Cancer Res Treat 96 197 202 1:CAS:528:DC%2BD28XivVent74%3D 10.1007/s10549-005- 9079-6 16319982
12. J Liu X Zhai G Jin Z Hu S Wang X Wang J Qin J Gao H Ma Q Wei H Shen 2006 Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population Int J Cancer 118 2554 2558 1:CAS:528:DC%2BD28XktlGhsr4%3D 10.1002/ijc.21652 16358261
13. KC Smith AC Bateman HM Fussell WM Howell 2004 Cytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur J Immunogenet 31 167 173 1:CAS:528:DC%2BD2cXnsFSjsr8%3D 10.1111/j.1365-2370.2004.00462.x 15265021 (Pubitemid 39049861)
14. K Snoussi AD Strosberg N Bouaouina S Ben Ahmed L Chouchane 2005 Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma Eur Cytokine Netw 16 253 260 1:CAS:528: DC%2BD28XhvFKkt7c%3D 16464738
15. Z Wang Y Fu C Tang S Lu W Chu 2009 SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8,454 cases and 11,800 controls Breast Cancer Res Treat 10.1007/s10549-009-0648-y
16. J Lau JP Ioannidis CH Schmid 1997 Quantitative synthesis in systematic reviews Ann Intern Med 127 820 826 1:STN:280:DyaK1c%2FgtVOmuw%3D%3D 9382404
17. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
18. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188 1:STN:280:DyaL2s7gsVamtA%3D%3D 10.1016/0197-2456(86)90046-2 3802833 (Pubitemid 17189972)
19. CA Dinarello 1996 Biologic basis for interleukin-1 in disease Blood 87 2095 2147 1:CAS:528:DyaK28Xhs1CktLc%3D 8630372
20. EM El-Omar M Carrington WH Chow KE McColl JH Bream HA Young J Herrera J Lissowska CC Yuan N Rothman G Lanyon M Martin JF Fraumeni Jr CS Rabkin 2000 Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 398 402 1:CAS:528:DC%2BD3cXitlyltb4%3D 10.1038/35006081 10746728 (Pubitemid 30164342)